Eli Lilly's Foundayo Weight Loss Pill Approved by FDA, Set for April Launch

Original: Eli Lilly Foundayo weight loss pill price, side effects, dosage, treatment: When will sales for oral weight-loss drug begin?

The Economic Times•Apr 2, 20263 min

In a Nutshell

Eli Lilly's weight loss pill, Foundayo (orforglipron), has received FDA approval and will launch on April 6 at a price of $149 per month. The drug is expected to generate significant sales, competing with Novo Nordisk's offerings in the GLP-1 market, despite potential side effects including gastrointestinal issues.

Key Points

01Foundayo is a once-daily oral medication targeting the GLP-1 hormone.
02The pill is priced at $149 per month for self-pay customers.
03Analysts predict 2026 sales could reach between $1.5 billion and $2.8 billion.
04Common side effects include mild-to-moderate gastrointestinal issues.
05The drug carries a boxed warning about an increased risk of thyroid C-cell tumors.

In-Article Ad

Full Summary

Eli Lilly's weight loss pill, Foundayo (orforglipron), has secured approval from the U.S. Food and Drug Administration (FDA) and is set to launch on April 6. The medication, a once-daily oral treatment that targets the GLP-1 hormone, is priced at $149 per month for self-pay customers. In clinical trials, patients lost between 12% to 15% of their body weight. Analysts forecast that sales could reach between $1.5 billion and $2.8 billion by 2026, as it competes with Novo Nordisk's products. However, potential side effects include mild-to-moderate gastrointestinal issues, and the drug comes with a boxed warning regarding an increased risk of thyroid C-cell tumors, similar to warnings for Novo's products. Eli Lilly has also submitted Foundayo for approval in over 40 countries.

Key Figures

$149

Monthly cost for self-pay customers

12% to 15%

Percentage of body weight lost in trials

$1.5 billion to $2.8 billion

Projected sales by 2026

40

Number of countries where approval has been submitted

In-Article Ad

Why It Matters

The launch of Foundayo may provide a new weight loss option for many Americans, potentially impacting healthcare costs and access to effective treatments.

Who is affected

Individuals seeking weight loss solutions, healthcare providers, and insurance companies.

What to know

Patients interested in Foundayo should consult their healthcare providers to discuss its suitability and potential side effects.

FAQ

The Foundayo pill is priced at $149 per month for self-pay customers.

Foundayo will be available starting April 6, 2024.

✦